Decoding the mechanisms of cell-cell fusion
解读细胞与细胞融合的机制
基本信息
- 批准号:10183001
- 负责人:
- 金额:$ 4.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-04 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Biological MarkersBiopsyBirth PlaceCancer BiologyCell fusionCellsCessation of lifeDisseminated Malignant NeoplasmDistantEpithelialEpitheliumGenesHumanHybrid CellsHybridsIn VitroInvadedLeukocytesMalignant NeoplasmsMediatingModelingMolecularNeoplasm MetastasisOrganPhysiologicalPrimary NeoplasmProcessResearchRoleSiteSupporting CellTissuesTractionUncertaintycancer cellcancer therapycancer typelive cell imagingmacrophagemigrationneoplastic cellnovel therapeutic interventionnovel therapeuticsperipheral bloodsingle-cell RNA sequencing
项目摘要
Project Summary
Cancer metastasis accounts for approximately 90% of cancer-associated deaths, yet the mechanisms underlying
this process remain the least understood aspect of cancer biology. During metastasis, tumor cells spread from
the primary tumor to surrounding tissues and to distant organs. The most intriguing aspect of cancer metastasis
is that despite the epithelial origin of most primary tumors, these tumor cells gain the ability to detach, invade
and migrate, such that they can escape their birth place and reach a distant site. What induces such dramatic
changes in the primary tumor cells? An interesting possibility is that cancer cells may acquire their migratory
potential by fusing with migratory cells, such that the many genes expressed by the latter can be hijacked by
cancer cells to promote their migration. Such cancer cell fusion hypothesis has been around for over a century,
and the migratory cells are proposed to be leukocytes, such as macrophages. Indeed, various types of cancer
cells have been shown to fuse with macrophages in vitro. Moreover, hybrid cells with biomarkers of both cancer
cells and leukocytes have been observed in human cancer biopsies and peripheral blood. However, the
percentage of the cancer cell-macrophage hybrids indicated by double positive biomarkers is relatively low (1-
20%), raising questions about the physiological relevance of cancer cell-macrophage fusion (CMF) in cancer
metastasis. In addition, no one has observed CMF at the primary tumor site, and the molecular mechanism
underlying such fusion remains completely unknown. Therefore, the CMF model has gained little traction in the
metastasis field to date. Despite these uncertainties, the presence of CMF in various metastatic cancers, albeit
detected at a low level, makes the model appealing nevertheless. Moreover, it is well known that the intrinsically
fusion-prone macrophages can infiltrate the TME and settle right next to cancer cells, making CMF physically
possible. I propose to detect the presence of cancer cell-macrophage hybrid using single cell RNAseq, visualize
cancer cell-macrophage fusion using live cell imaging, and identify the molecular components mediating cancer
cell-macrophage fusion. If definitive evidence can be obtained to support the CMF model, this will bring about a
paradigm shift in our understanding of cancer metastasis and provide basis for novel therapeutic approaches for
cancer treatment.
项目概要
癌症转移约占癌症相关死亡的 90%,但其背后的机制
这一过程仍然是癌症生物学中最不为人所知的方面。在转移过程中,肿瘤细胞从
原发肿瘤扩散至周围组织和远处器官。癌症转移最有趣的方面
尽管大多数原发性肿瘤的上皮起源,但这些肿瘤细胞获得了分离、侵袭的能力
并迁徙,以便他们能够逃离出生地,到达遥远的地方。是什么引发了如此戏剧性的事件
原发肿瘤细胞的变化?一个有趣的可能性是癌细胞可能会获得迁移能力
与迁移细胞融合的潜力,使得后者表达的许多基因可以被劫持
癌细胞以促进其迁移。这种癌细胞融合假说已经存在一个多世纪了,
并且迁移细胞被认为是白细胞,例如巨噬细胞。事实上,各种癌症
细胞已被证明可以在体外与巨噬细胞融合。此外,具有两种癌症生物标志物的杂交细胞
在人类癌症活检和外周血中已观察到细胞和白细胞。然而,
双阳性生物标志物表明的癌细胞-巨噬细胞杂交体的百分比相对较低(1-
20%),提出了关于癌细胞-巨噬细胞融合(CMF)在癌症中的生理相关性的问题
转移。另外,目前还没有人在原发肿瘤部位观察到CMF,其分子机制
这种融合的背后仍然完全未知。因此,CMF 模型在业界几乎没有获得什么关注。
迄今为止的转移领域。尽管存在这些不确定性,CMF 在各种转移性癌症中的存在,尽管
尽管检测到的水平较低,但该模型仍具有吸引力。此外,众所周知,本质上
易于融合的巨噬细胞可以渗透 TME 并定居在癌细胞旁边,从而使 CMF 物理化
可能的。我建议使用单细胞 RNAseq 检测癌细胞-巨噬细胞杂交体的存在,可视化
使用活细胞成像进行癌细胞-巨噬细胞融合,并鉴定介导癌症的分子成分
细胞-巨噬细胞融合。如果能够获得确凿的证据来支持CMF模型,这将带来
我们对癌症转移的理解发生了范式转变,并为新的治疗方法提供了基础
癌症治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth H Chen其他文献
Elizabeth H Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth H Chen', 18)}}的其他基金
Skeletal Muscle: Development, Regeneration and Disease
骨骼肌:发育、再生和疾病
- 批准号:
10237575 - 财政年份:2021
- 资助金额:
$ 4.27万 - 项目类别:
Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model
以斑马鱼为模型研究脊椎动物成肌细胞融合机制
- 批准号:
10213657 - 财政年份:2020
- 资助金额:
$ 4.27万 - 项目类别:
Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model
以斑马鱼为模型研究脊椎动物成肌细胞融合机制
- 批准号:
10408109 - 财政年份:2020
- 资助金额:
$ 4.27万 - 项目类别:
Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model
以斑马鱼为模型研究脊椎动物成肌细胞融合机制
- 批准号:
10628046 - 财政年份:2020
- 资助金额:
$ 4.27万 - 项目类别:
相似国自然基金
基于微球透镜阵列的一体化检测芯片及其在肿瘤“液体活检”中应用的关键技术研究
- 批准号:62375121
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
利用三维卷积神经网络挖掘超声内镜成像特征精准引导胰腺癌细针穿刺活检的辅助诊断模型
- 批准号:82373118
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于明场微视觉动态三维感知的胚胎活检微纳操作机器人导引关键技术研究
- 批准号:52305023
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多维临床和大数据MRI影像组学“虚拟活检”技术对乳腺癌术后远处转移预测模型研究
- 批准号:82302302
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于小细胞外囊泡的均相液体活检方法及其动态监测Oxaliplatin治疗HCC新型标志物研究
- 批准号:82372344
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目